Improving Dementia Care in Nursing Homes Through Best Care Practices

Size: px
Start display at page:

Download "Improving Dementia Care in Nursing Homes Through Best Care Practices"

Transcription

1 Improving Dementia Care in Nursing Homes Through Best Care Practices Morris J. Kaplan, Esq., NHA President, Kaplan Health Management, LLC Operating Partner, Gwynedd Square Nursing Center 5 Star Rated by US Govt. Copyright 2012 Morris J. Kaplan. All rights reserved. 773 Sumneytown Pike Lansdale, PA

2 Goal: To reduce the use of antipsychotics in residents with dementia (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

3 Black Box Warning Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. between 1.6 to 1.7 times the risk of death most either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia).

4 American Psychiatric Association Doctors: Anti-psychotic meds overused for dementia, kids * \ *USA TODAY - September 23, 2013 Anti-psychotic medications should not be the first treatments doctors or patients think of when dealing with dementia in an elderly person, behavior problems in a child or insomnia in an adult. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

5 American Psychiatric Association & American Medical Directors Association Don t prescribe antipsychotic medications for behavioral and psychological symptoms of dementia (BPSD) in individuals with dementia without an assessment for an underlying cause of the behavior. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

6 Report by Office of Inspector General US Department of Health and Human Services 83% (1,197,442) of atypical antipsychotic drug claims were for elderly nursing home residents diagnosed with conditions for which the drugs use was not approved by FDA (i.e., the drugs were used off-label). 88% (1,263,641) were for residents diagnosed with dementia. May 2011 Department of Health and Human Services, Office of Inspector General (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

7 Record Penalties (or just a cost of doing business?) January 2009 drug company Eli Lilly & Co. agreed to pay $1.4 billion to resolve allegations of off-label promotion of the anti-psychotic Zyprexa. November 2009 Omnicare pays US $98 million settlement to resolve allegations that it received kickbacks to recommend drugs, including Risperdal (an atypical antipsychotic), for use in nursing homes. May 2012 Abbott Laboratories settled for $1.6 billion over its marketing of the anti-seizure drug Depakote July 2012 Glaxo Agrees to Pay $3 Billion in Fraud Settlement improper marketing of drugs July 2012 Johnson and Johnson Ordered to Pay $2.2 Billion in Risperdal Settlement August 2012 Johnson and Johnson subsidiary Janssen Pharmaceuticals, Inc. agrees to $181 Million Settlement of Off-Label Drug Marketing Allegations.

8 Goal: To reduce the use of antipsychotics in residents with dementia It s over 26 years since the Nursing Home Reform Act of 1987! More than a quarter century has passed since the start of the campaign to end physical and chemical restraints in nursing homes. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

9 Antipsychotic Use July 2012 National Nursing Home Average: 23.9% September 2013 Gwynedd Square Nursing Center: 9% (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

10 The Wall Street Journal August 26, 2013 by Lucette Lagnado Effort to reduce use of antipsychotic drugs falls short of goal $7.6 billion spent by Medicare Part D on antipsychotics in 2011 In 2011, the Inspector General 88% of the time, the drugs had been prescribed to patients suffering from dementia a situation he later said was "potentially most alarming.

11 Affordable Care Act (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

12

13

14

15

16

17 Key: To make people feel good and happy about themselves Use individualized, person-centered care practices Make people with dementia feel happy and good about themselves Reduce the incidence of significant behavioral symptoms Reduce the need for antipsychotic, antianxiety and hypnotic drugs Reduce the risk of falls (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

18 Pharmacological Approaches to Behavioral Symptoms Antipsychotic medication can be appropriate when using the lowest possible dose of medication, for the shortest possible duration, helps to maintain the resident s highest level of psychosocial & physical well being. Interdisciplinary communication is critical to insure that the resident is functioning at his/her highest level. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

19 Basic Prerequisites for Good Care Leadership ownership & management must be active & involved; board, corporate executives, Administrator, DON Quality improvement comes from the top down. Adequate Staffing with consistent assignments ratio of CNAs to residents by shift: 1 st shift 1:8 2 nd shift 1:9 3 rd shift 1:16 Interdisciplinary Communication that includes the resident and/or family representatives (to the extent possible) Adequate Medicaid Rates (also, Medicare) (C) Copyright 2012 by Morris J. Kaplan. All

20 Gwynedd Square Nursing Center, Lansdale, PA 75% Medicaid 181 beds for profit not part of a chain family owned & operated since 1980 (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

21 Key to managing behavioral symptoms: Helping to guide confused residents through their day by keeping them active, engaged and monitored in level-appropriate activities & dining programs. (And also letting them take naps whenever they want to). (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

22 Individualized Activity & Dining Programs at Gwynedd Square Offer 5, level-appropriate, activity programs Employ 11 activity staff members for approximately 181 residents (All activity staff are trained to assist residents, as needed, with meals.) Provide 3 different dining programs for lunch & dinner A resident can be kept active, engaged and monitored in levelappropriate activity and dining programs for much of the day. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

23 Activity Programs Friendship Club early stage dementia Sunshine Club late stage dementia Rising Stars Program high fall risk, late stage dementia Korean Elders Program includes 41 out of 181 residents Alert & Oriented Group and whole community functions (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

24 (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

25 (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

26 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

27 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

28 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

29 At later stages of life, people with dementia require assistance with eating. Without help eating, these people will lose weight. If you help people with dementia to eat, they are much less likely to lose weight. Key: Eating at the resident s own pace and arranging the staff schedule to fit the pace of the residents. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

30 At Admission September 2012 at Gwynedd Square (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

31 At Admission September 2012 at Gwynedd Square (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

32 At Admission September 2012 at Gwynedd Square (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

33 July 2012 Gwynedd Square National Average residents who lose too much weight 4.9% 7.2% source: CMS Nursing Home Compare website (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

34 Dining Programs (60-90 minutes) Main Dining Room independent dining -- includes some total assist tables Lunch Bunch & Supper Club early & middle stage dementia -- enabling residents with memory impairment through cueing, directing and assisting Lakeside Dining Program late stage dementia/cva -- total feeding assistance (C) Copyright 2013, 2013 by Morris J. Kaplan. All Rights Reserved.

35 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

36 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

37 Lakeside Dining Program total feeding assistance (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

38 (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

39 the substitute for seroquel Keeping people active, engaged and monitored throughout the day through activity programming + specialized dining programs. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

40 Behavioral symptoms can be observed, anticipated, redirected and minimized, and the use of antipsychotic medication can be reduced or avoided. (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

41 Best Practices Required for a Successful Program to Reduce Antipsychotic Use: At admission information is obtained from the family on resident s preferences/routine/major life experiences/positive interventions. The information obtained at admission on resident s preferences/routine/positive interventions, etc. is conveyed in person (not simply in writing) on the day of admission by admissions or social service staff to the resident s direct care nurse and CNA(s). CNA to Resident Ratio 1 st shift nd shift rd shift 1-16 Facility has permanent assignments (same CNA to same resident 5 days/week). Administrator & DON regularly attend care plan meetings. Family is strongly encouraged to attend either in person or by speakerphone. Administrator & DON review monthly Facility Quality Measures Report from CMS and use it to identify residents with poor outcomes who need improved or different care interventions. (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

42 Best Practices Required for a Successful Program to Reduce Antipsychotic Use: Administrator & DON review pharmacy consultant s report quarterly (with pharmacy consultant, medical director). Each month, Administrator & DON use Quality Measures report, along with the pharmacy consultant report, to identify residents appropriate for possible reduction/elimination of antipsychotics. Administrator & DON together with family and care plan team are involved in the process to find effective interventions to address behavioral symptoms. The facility provides at least two different level activities programs twice daily (one for higher functioning residents and one for lower functioning residents). Key Performance Indicator: Monthly Facility Quality Measure Report - percentage of residents on antipsychotics & comparison to state and national averages (C) Copyright 2012 by Morris J. Kaplan. All Rights Reserved.

43 Morris J. Kaplan, Esq., NHA Kaplan Health Management, LLC Gwynedd Square Nursing Center (215) (C) Copyright 2013, 2012 by Morris J. Kaplan. All Rights Reserved.

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Integrating INTERACT into Interim Pharmacist Reviews

Integrating INTERACT into Interim Pharmacist Reviews Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy

More information

Food and Drug Administration Office of Criminal Investigations

Food and Drug Administration Office of Criminal Investigations 1 of 7 2/13/2014 9:30 PM Home Inspections, Compliance, Enforcement, and Criminal Investigations Criminal Investigations Inspections, Compliance, Enforcement, and Criminal Investigations November 4, 2013:

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

9/11/2012. Clare I. Hays, MD, CMD

9/11/2012. Clare I. Hays, MD, CMD Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management

More information

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia Amy J. Osborn, NHA, PMP Executive Director, Health Services Advisory Group (HSAG) Rick Foley, PharmD,

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega) Reference Number: CP. PMA.10.11.19 Effective Date: 10.06.16 Last Review Date: 04.18 Line of Business: CenpaticoMedicaid Revision Log See Important Reminder at the end of this

More information

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES Kelly Bagby and Iris Gonzalez kbagby@aarp.org (202) 434-2103 igonzalez@aarp.org (202) 434-6289

More information

Vanderbilt & Qsource Webinar Series

Vanderbilt & Qsource Webinar Series Vanderbilt & Qsource Webinar Series Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances

More information

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed

More information

12/17/2012. Unnecessary Drugs

12/17/2012. Unnecessary Drugs Nursing Home Social Work Webinar Series December 19, 2012 Dr. Robin P. Bonifas, PhD, MSW Arizona State University School of Social Work Importance of familiarity with psychotropic medication regulations.

More information

National Litigation Trends

National Litigation Trends National Litigation Trends Caroline M. Brown, Esq. Covington & Burling LLP NASMHPD/NASDDDS Legal Divisions Meeting November 13, 2012 Certification of Psychiatric Hospitals Pending OIG audits in several

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Vraylar) Reference Number: CP.PMN.91 Effective Date: 11.16.16 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

RCFE ADMINISTRATOR INITIAL CERTIFICATION PROGRAM

RCFE ADMINISTRATOR INITIAL CERTIFICATION PROGRAM RCFE ADMINISTRATOR INITIAL CERTIFICATION PROGRAM Day 6 DAY 6 1) Dementia Care Definitions Types/causes Managing behavioral challenges Medications Regulatory requirements Staff training Medications in dementia

More information

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND Sandra Brownstein, PharmD, CGP Objectives: List potential medication related problems that increase in the frail elderly with acute illness Differentiate

More information

Antipsychotic use in Dementia care. Jabbar Fazeli, MD

Antipsychotic use in Dementia care. Jabbar Fazeli, MD Antipsychotic use in Dementia care Jabbar Fazeli, MD www.mainegeriatrics.com What changed in 2012? NY times- May 9, 2011!! Antipsychotic Drugs Called Hazardous for the Elderly - referencing the OIG audit

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Saphris) Reference Number: CP.PMN.15 Effective Date: 12.01.14 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important Reminder

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters.

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters. New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm Call-In Information: 1-888-895-6448 Code: 7362894 Log-In Information: https://qualidigm.adobeconnect.com/affinity/

More information

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate

More information

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts ( ) April 2017

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts ( ) April 2017 Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021) April 2017 Global Long Acting Injectable Anti-psychotic Market Report Scope of the Report The report entitled Global

More information

Title: Antipsychotic Use in Persons with Dementia CMS ID: ARCO3 NQF #: N/A

Title: Antipsychotic Use in Persons with Dementia CMS ID: ARCO3 NQF #: N/A Source(s) Pharmacy Quality Alliance (PQA). Technical specifications for PQA approved measures. Springfield (VA): Pharmacy Quality Alliance (PQA); 2015 Jul. 66 p. Measure Domain Clinical Quality Measures:

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Hello everyone. Today we will be discussing the

More information

Benzodiazepine Misuse Abuse - Dependence Using for recreational purposes Continued long term use against medical advise Use of drug with other potenti

Benzodiazepine Misuse Abuse - Dependence Using for recreational purposes Continued long term use against medical advise Use of drug with other potenti Benzodiazepine Prescribing In Primary Care Settings: Issue for Concern? Louis E. Baxter, Sr., M.D., FASAM Executive Medical Director Professional Assistance Program, New Jersey, Inc. Benzodiazepine Misuse

More information

Behavioral Health Evaluation

Behavioral Health Evaluation This document is intended to serve as a template for a behavioral health committee meeting in an extended care facility. The State Operations Manual (SOM), Appendix PP - "Guidance to Surveyors for Long

More information

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document. Enclosure No: Agenda item No: Author: Contact: xx/xxxxx/xxxx0918 xx CEPP National Audit: Antipsychotics in Dementia All Wales Therapeutics and Toxicology Centre Tel: 02920 71 6900 awttc@wales.nhs.uk 1.0

More information

Introducing ValueOptions Clinical Care Alerts

Introducing ValueOptions Clinical Care Alerts Introducing ValueOptions Clinical Care Alerts January 2013 Agenda What are Clinical Care Alerts? How does it work? What are the benefits? Questions and Answers 2 The Issue of Poor Medication Adherence

More information

COMFORT AS THE NEW MEDICINE: Reducing Psychotropic Medications. Tena Alonzo, MA Beatitudes Campus

COMFORT AS THE NEW MEDICINE: Reducing Psychotropic Medications. Tena Alonzo, MA Beatitudes Campus COMFORT AS THE NEW MEDICINE: Reducing Psychotropic Medications Tena Alonzo, MA Beatitudes Campus Learning Objectives: Describe three specific techniques that promote comfort for people with dementia. Define

More information

Corporate Membership Application

Corporate Membership Application Our Vision Corporate Membership Application The Rotary Club of Calgary (the Club ) is an organization of business, professional, and community leaders who come together through commitment and fellowship

More information

Antidepressants for treatment of depression.

Antidepressants for treatment of depression. JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Rexulti) Reference Number: CP.PMN.68 Effective Date: 11.05.15 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important Reminder

More information

Increasing Use of Psychotropics

Increasing Use of Psychotropics A Critical Curriculum on Psychotropic Medications A Critical Curriculum on Psychotropic Medications Principal Investigator: David Cohen, Ph.D. Professional Consultants: David O. Antonuccio, Ph.D. (psychology)

More information

OPERATION: They have a 7 member Board of Directors (local Manatee area folks).

OPERATION: They have a 7 member Board of Directors (local Manatee area folks). FLORIDA DOG GUIDES F.T.D. Inc 2016 27 th Street East Bradenton, FL 34208 (941) 748-8245 WHO ARE THEY? A statewide program serving the needs of the deaf/hearing impaired residents of Florida that use trained

More information

Test your Knowledge: Recognizing Delirium

Test your Knowledge: Recognizing Delirium The Ottawa Hospital Name: Unit: Profession: RN RPN PT OT SW Other Note: Each question has only one correct answer. 1. If a patient is identified as being at high risk for developing delirium, his/her mental

More information

Reduction of High Risk Medications Using A Quality Initiative Perspective

Reduction of High Risk Medications Using A Quality Initiative Perspective Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what

More information

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle (Estradiol Transdermal System)

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle (Estradiol Transdermal System) Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses New 0.025

More information

Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: Last Review Date: 02.

Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: Last Review Date: 02. Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: 08.01.15 Last Review Date: 02.18 Line of Business: Medicaid Revision Log See Important Reminder

More information

Communication with Cognitively Impaired Clients For CNAs

Communication with Cognitively Impaired Clients For CNAs Communication with Cognitively Impaired Clients For CNAs This course has been awarded one (1.0) contact hour. This course expires on August 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction

More information

There is a significant relationship between restlessness and agitation induced by medicine and the propensity for violence, Kruszewski said.

There is a significant relationship between restlessness and agitation induced by medicine and the propensity for violence, Kruszewski said. 1 of 6 5/29/2007 8:49 AM Tacoma, WA - Tuesday, May 29, 2007 < Back to Regular Story Page Drugs might breed violence Attacks on staff rise at Western State Hospital M. ALEXANDER OTTO; The News Tribune Last

More information

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department

More information

Improving Dementia Care in Maryland Nursing Homes: A Patient Safety Initiative

Improving Dementia Care in Maryland Nursing Homes: A Patient Safety Initiative Improving Dementia Care in Maryland Nursing Homes: A Patient Safety Initiative March 14, 2014 Susan M. Levy, MD, CMD VPMA Levindale 2 Susan M. Levy, MD-Disclosures VPMA Levindale Physician consultant for

More information

Managing Fatigue or Tiredness

Managing Fatigue or Tiredness Managing Fatigue or Tiredness The following information is based on the general experiences of many prostate cancer patients. Your experience may be different. If you have any questions about what prostate

More information

Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol

Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol 483.25 Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol 2 483.25 End of Life Each resident must receive and the facility must provide the necessary care and services to attain

More information

Tool Kit. GBFB.org/holidaymeals. Together, we ll help to distribute more than 12 million healthy meals this holiday season.

Tool Kit. GBFB.org/holidaymeals. Together, we ll help to distribute more than 12 million healthy meals this holiday season. Thank you for joining The Greater Boston Food Bank s (GBFB) seventh annual Holiday Meal Drive. Your efforts will help to provide healthy holiday meals to those in need across Eastern Massachusetts who

More information

Sample policy A (Includes parking lots and company-owned vehicles) Policy Statement:

Sample policy A (Includes parking lots and company-owned vehicles) Policy Statement: Sample policy A (Includes parking lots and company-owned vehicles) Policy Statement: Tobacco use is not permitted at any time, during and beyond working hours within any [employer] facility, whether owned

More information

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Update in Geriatrics: Choosing Wisely Primum Non Nocere Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor

More information

The audit is managed by the Royal College of Psychiatrists in partnership with:

The audit is managed by the Royal College of Psychiatrists in partnership with: Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of

More information

Massachusetts Department of Developmental Services Medication Review

Massachusetts Department of Developmental Services Medication Review University of Massachusetts Medical School escholarship@umms Commonwealth Medicine Publications Commonwealth Medicine 8-7-2012 Massachusetts Department of Developmental Services Medication Review Alexandra

More information

Tip Sheet Individualizing Night Time Routines

Tip Sheet Individualizing Night Time Routines Tip Sheet Individualizing Night Time Routines WHAT IT IS Individualizing night time routines means following residents individual customary routines for how they spend their evening and the time they are

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care

Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care Appendices Appendix A Psych Meds Data Indicators by State The data elements being collected by the

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Massachusetts Department of Developmental Services. Medication Review

Massachusetts Department of Developmental Services. Medication Review Massachusetts Department of Developmental Services Medication Review NASDDDS Reinventing Quality August 7, 2012 Alixe Bonardi 1, Gail Grossman 2 Emily Lauer 1 1 University of Massachusetts Medical School

More information

From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events

From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events Michael Wasserman, MD, CMD Executive Director, Care Continuum Health Services Advisory Group September 15, 2016 Quality

More information

Fall Risk Assessment and Prevention in the Post-Acute Setting A Road Map

Fall Risk Assessment and Prevention in the Post-Acute Setting A Road Map Fall Risk Assessment and Prevention in the Post-Acute Setting A Road Map Cora M. Butler, JD, RN, CHC HealthCore Value Advisors, Inc. Juli A. James, RN Primaris Holdings, Inc. Objectives Explore the burden

More information

Transforming Care for the Elderly

Transforming Care for the Elderly Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome

More information

CALIFORNIA LEAFY GREEN PRODUCTS. Summary Report of Findings

CALIFORNIA LEAFY GREEN PRODUCTS. Summary Report of Findings CALIFORNIA LEAFY GREEN PRODUCTS 2007 SIGNATORY SURVEY Summary Report of Findings Presented to: Mr. Scott Horsfall Chief Executive Officer California Leafy Green Products Handler Marketing Agreement Sacramento,

More information

Meet the many faces of pain

Meet the many faces of pain Meet the many faces of pain WWW.PRIALT.COM N O W M E E T Ziconotide is a synthetic equivalent of a naturally occurring conopeptide. Distributed by Elan Pharmaceuticals, Inc. (EPI). PRIALT is a registered

More information

Draft Falls Prevention Strategy

Draft Falls Prevention Strategy Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention

More information

ProviderNews FEBRUARY

ProviderNews FEBRUARY ProviderNews FEBRUARY 2017 Reminder: decimal billing required on time-based therapy codes for BadgerCare Plus members In accordance with Forward Health guidelines, Security Health Plan requires decimal

More information

National Council of Certified Dementia Practitioners

National Council of Certified Dementia Practitioners National Council of Certified Dementia Practitioners The Global Leader in Dementia Education and Certification Contact: Sandra Stimson CALA ADC AC-BC CADDCT CDP CDCM Chief Executive Officer 55 Main Street

More information

Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis

Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis A joint publication of the Illinois Health Care Association and CE Solutions November 2015 Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis Early diagnosis

More information

Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia

Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia 4 June 2015 details Name of organisation Royal Australian College of General Practitioners () Postal Address Legal

More information

Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol

Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol 483.25 Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol 2 483.25 End of Life Each resident must receive and the facility must provide the necessary

More information

Risks of Antipsychotics use In Dementia

Risks of Antipsychotics use In Dementia AHCA/NCAL Quality Initiative for Assisted Living Webinar Series: Safely Reducing the Off-Label Use of Antipsychotics Risks of Antipsychotics use In Dementia Sanjay P. Singh, MD Chairman & Professor, Department

More information

Note: Attendees can earn up to 6.0 CPE Hours

Note: Attendees can earn up to 6.0 CPE Hours Texas ASCP Chapter Spring Continuing Education Program April 18, 2015 Texas Tech University Health Sciences Center * Dallas, TX School of Pharmacy- Dallas/Fort Worth 5920 Forest Park Road, Suite Note:

More information

The Age of Audits. The Age of Audits Optometry has never been targeted has that changed? What would you do??? The Age of Audits DISCLAIMER

The Age of Audits. The Age of Audits Optometry has never been targeted has that changed? What would you do??? The Age of Audits DISCLAIMER Is this the Golden Age of audits? Joe W DeLoach, OD, FAAO CEO, Optometric Business Solutions Optometry has never been targeted has that changed? If you are filing claims, you are a target! DISCLAIMER I

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

Cost of Mental Health Care

Cost of Mental Health Care Section 4 Cost of Mental Health Care Per capita mental health spending for Americans with a mental health diagnosis has increased among children, peaking in. For adults, the spending has been more stable.

More information

Corporate Presentation. August 2016

Corporate Presentation. August 2016 v Corporate Presentation August 2016 Safe harbor statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,

More information

Understanding the Value of Generic Drugs

Understanding the Value of Generic Drugs Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher

More information

To Prescribe or Not To Prescribe

To Prescribe or Not To Prescribe To Prescribe or Not To Prescribe AzSHRM Quarterly Meeting May 11, 2018 Presented by: Karen Wright, RN BSN ARM CPHRM MICA Senior Risk Management Consultant 1 OBJECTIVES List three common classes of medications

More information

An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care

An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care John G. Abbott Deputy Minister, Department of Health and

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Dental Status and Services Critical Element Pathway

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Dental Status and Services Critical Element Pathway Use this pathway for a resident having oral/dental problems such as broken, carious, or loose teeth; inflamed gums; mouth sores or mouth pain; denture problems; or chewing problems. If mouth or facial

More information

Hospice and Palliative Care An Essential Component of the Aging Services Network

Hospice and Palliative Care An Essential Component of the Aging Services Network Hospice and Palliative Care An Essential Component of the Aging Services Network Howard Tuch, MD, MS American Academy of Hospice and Palliative Medicine Physician Advocate, American Academy of Hospice

More information

Dementia Care Principles

Dementia Care Principles New CMS Surveyor Guidance: Care & Services for a Resident with Dementia Cat Selman, BS www.thehealthcarecommunicators.com 2015 The Healthcare Communicators, Inc. All rights reserved. Dementia Care Principles

More information

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher Non-pharmacological Approaches in Dementia Care Dr. Anna Fisher What is Dementia Dementia is a group of symptoms that may accompany certain diseases or conditions Symptoms many involve changes in personality,

More information

Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider.

Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider. Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider. 1 Benefits of Clozapine Clozapine may work when other medications don t. Doctors

More information

Clinical Policy: Olanzapine Orally Disintegrating Tablet (Zyprexa Zydis) Reference Number: CP.PMN.29 Effective Date: Last Review Date: 02.

Clinical Policy: Olanzapine Orally Disintegrating Tablet (Zyprexa Zydis) Reference Number: CP.PMN.29 Effective Date: Last Review Date: 02. Clinical Policy: (Zyprexa Zydis) Reference Number: CP.PMN.29 Effective Date: 08.01.15 Last Review Date: 02.19 Line of Business: Medicaid See Important Reminder at the end of this policy for important regulatory

More information

Managing Challenging Behaviors

Managing Challenging Behaviors Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine In partnership with Drs. Lorin Scher, MD and Vicki Wheelock, MD 1 Our Goal

More information

REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA Executive Summary Schizophrenia Sales in the US, 2012 The combined sales of medications carrying an indication in schizophrenia in

More information

Rational Medication Use in Dementia

Rational Medication Use in Dementia Rational Medication Use in Dementia Stephen Thielke sthielke@u.washington.edu (206) 764 2815 I have no conflicts of interest to report. I am an employee of the federal government. The opinions in this

More information

IMPLEMENTING THE WHO GLOBAL DEMENTIA ACTION PLAN. Glenn Rees, Chair Alzheimer s Disease International (ADI)

IMPLEMENTING THE WHO GLOBAL DEMENTIA ACTION PLAN. Glenn Rees, Chair Alzheimer s Disease International (ADI) IMPLEMENTING THE WHO GLOBAL DEMENTIA ACTION PLAN Glenn Rees, Chair Alzheimer s Disease International (ADI) Presented at the 20 th Asia Pacific Regional Conference of ADI in Jakarta, Indonesia My thanks

More information

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue. Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union

More information

Using Big Data to Empower Consumer Choice. Oregon State of Reform Health Policy Conference September 24, 2014

Using Big Data to Empower Consumer Choice. Oregon State of Reform Health Policy Conference September 24, 2014 Using Big Data to Empower Consumer Choice Oregon State of Reform Health Policy Conference September 24, 2014 Agenda Big data Ideal state for consumers The best and worst of health information What is coming

More information

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State RAI/MDS Coordinator Objectives Upon completion of this training,

More information

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of

More information

Medication Therapy Management: Improving Health and Saving Money

Medication Therapy Management: Improving Health and Saving Money Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system

More information

Medication Treatment of Cognitive and Behavioral Symptoms in Dementia

Medication Treatment of Cognitive and Behavioral Symptoms in Dementia Medication Treatment of Cognitive and Behavioral Symptoms in Dementia Cary J. Kohlenberg, M.D. Medical Director, IPC Research and Independent Psychiatric Consultants Environmental interventions directly

More information

Promotional Messaging in Health Care Off-Label Promotion, Reprint Usage and Social Media

Promotional Messaging in Health Care Off-Label Promotion, Reprint Usage and Social Media Promotional Messaging in Health Care Off-Label Promotion, Reprint Usage and Social Media June 2014 Monica Chmielewski, Esq. Special Counsel Foley & Lardner LLP Robin Seifert, Esq. Assistant General Counsel

More information

BRIGHAM AND WOMEN S FAULKNER HOSPITAL ADULT INPATIENT PSYCHIATRY ADVANCED PRACTICUM TRAINING PROGRAM

BRIGHAM AND WOMEN S FAULKNER HOSPITAL ADULT INPATIENT PSYCHIATRY ADVANCED PRACTICUM TRAINING PROGRAM BRIGHAM AND WOMEN S FAULKNER HOSPITAL ADULT INPATIENT PSYCHIATRY ADVANCED PRACTICUM TRAINING PROGRAM 2019-2020 Christopher AhnAllen, Ph.D. Director of Inpatient Psychology and Psychology Education 1153

More information

Approved Care Model for Project 3gi: Integration of Palliative Care into the PCMH Model

Approved Care Model for Project 3gi: Integration of Palliative Care into the PCMH Model 1 Approved Care Model for Project 3gi: Integration of Palliative Care into the PCMH Model OneCity Health Webinar January 13, 2016 Overview of presentation 2 Approach to care model development Project overview

More information

Electroconvulsive Therapy (ECT)

Electroconvulsive Therapy (ECT) Electroconvulsive Therapy (ECT) UHN Information for patients and families Read this booklet to learn: What ECT is and how it works How to prepare for the treatment What you can expect Some side effects

More information

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership

More information

Informed Consent for Weight Management Treatment & Appetite Suppressants Voluntary Enrollment

Informed Consent for Weight Management Treatment & Appetite Suppressants Voluntary Enrollment Informed Consent for Weight Management Treatment & Appetite Suppressants Voluntary Enrollment I am voluntarily enrolling in an aggressive weight management program. I hereby authorize Dr. Britton and his

More information

January 2, Dear Technical Review Committee Members:

January 2, Dear Technical Review Committee Members: Glenn A. Ally, Ph.D., M.P. (A Professional Psychology Corporation) Clinical Neuropsychologist Advanced Practice Medical Psychologist 155 Hospital Drive, Suite 200 Lafayette, Louisiana 70503 (337) 235-8304

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information